Therapeutic Tender (Botulinum Toxin)
The therapeutic tender is a new model for tendering where suppliers were offered to submit prices on a percentage of market share they could achieve within a therapeutic class. The therapeutic areas tendered were carefully selected by the P&MM board.
Benefits of the contract
The therapeutic areas tendered were carefully selected by the MUP board.
Although some suppliers refused to tender others tendered additional discounts for increased market share. Some NHS trusts are now switching products to achieve these additional discounts.
Savings are reported on lines where there was a reduction in the acquistion cost of a drug or an NHS Trust has switched to a more cost effective agent in a therapeutic group